Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6584-6643
Author(s):
Roger Gilabert-Oriol, Alexander Weng, Benedicta von Mallinckrodt, Matthias F. Melzig, Hendrik Fuchs and Mayank Thakur
The Molecular Mechanisms of TRAIL Resistance in Cancer Cells: Help in Designing New Drugs
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6714-6722
Author(s):
Feng Wang, Junsheng Lin and Ruian Xu
Deregulated Expression of miR-224 and its Target Gene: CD59 Predicts Outcome of Diffuse Large B-cell Lymphoma Patients Treated with R-CHOP
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
659-670
Author(s):
Guoqi Song, Guorong Song, Huiyun Ni, Ling Gu, Hong Liu, Baoan Chen, Bangshun He, Yuqin Pan, Shukui Wang and William C. Cho
The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
621-637
Author(s):
Haleh Vosgha, Ali Salajegheh, Robert Anthony Smith and Alfred King-Yin Lam
Survey of Epstein Barr Virus (EBV) Immunogenic Proteins and their Epitopes: Implications for Vaccine Preparation
Journal:
Recent Patents on Anti-Infective Drug Discovery
Volume:
9
Page:
62-76
Author(s):
Julius Rajcani, Kalman Szenthe, Ferenc Banati and Susan Szathmary
Role of Prolyl Isomerase Pin1 in Pathogenesis of Diseases and Remedy for the Diseases from Natural Products
Journal:
Current Drug Targets
Volume:
15
Page:
973-981
Author(s):
Katsuhiko Takahashi, Taiki Shimizu, Keita Kosaka, Masafumi Hidaka, Chiyoko Uchida and Takafumi Uchida
Anti-Inflammatory Effects of Triterpenoids; Naturally Occurring and Synthetic Agents
Journal:
Mini-Reviews in Organic Chemistry
Volume:
11
Page:
316-329
Author(s):
Gil-Saeng Jeong and Jong-Sup Bae
An Update on Disease Modifying Antirheumatic Drugs
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
13
Page:
249-261
Author(s):
Poorvashree Joshi and Suneela S. Dhaneshwar
MiRNAs in Human Cancers: The Diagnostic and Therapeutic Implications
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5336-5347
Author(s):
Qiong Wu, Zhiping Yang, Yongquan Shi and Daiming Fan
Oncogenic MicroRNAs in the Genesis of Leukemia and Lymphoma
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5260-5267
Author(s):
Yanyan Pan, Mei Meng, Gaochuan Zhang, Hongyan Han and Quansheng Zhou